Late-onset Erythropoietic Protoporphyria Associated with Myelodysplastic Syndrome Treated with Azacitidine

Acta Derm Venereol. 2018 Feb 7;98(2):275-277. doi: 10.2340/00015555-2829.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Azacitidine / therapeutic use*
  • Disease Progression
  • Enzyme Inhibitors / therapeutic use*
  • Humans
  • Male
  • Myelodysplastic Syndromes / complications
  • Myelodysplastic Syndromes / diagnosis
  • Myelodysplastic Syndromes / drug therapy*
  • Protoporphyria, Erythropoietic / diagnosis
  • Protoporphyria, Erythropoietic / drug therapy*
  • Protoporphyria, Erythropoietic / etiology
  • Skin / drug effects*
  • Skin / pathology
  • Treatment Outcome

Substances

  • Enzyme Inhibitors
  • Azacitidine